The exogenous IP‐10 (intramuscular) was administered in the bleomycin‐induced pulmonary fibrosis murine model, which resulted in marked attenuation of pulmonary fibrosis that was entirely attributable to a reduction in angiogenesis in the lung21. The gene discussed is CXCL10; the disease is pulmonary fibrosis.